| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.16B | +16.4% |
| Cost of Revenue | $609.4M | +21.0% |
| Gross Profit | $1.55B | +14.7% |
| R&D Expense | $520.3M | +36.2% |
| SG&A Expense | $217.6M | +26.9% |
| Operating Income | $459.1M | -9.2% |
| Pre-tax Income | $509.1M | -0.6% |
| Income Tax | $21.4M | -74.8% |
| Net Income | $487.7M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $886.5M | -22.1% |
| Accounts Receivable | $703.1M | +11.4% |
| Current Assets | $3.97B | +27.7% |
| Total Assets | $4.80B | +25.9% |
| Current Liabilities | $1.01B | +19.7% |
| Total Liabilities | $1.09B | +20.2% |
| Stockholders' Equity | $3.72B | +27.6% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $780.5M | +2.1% |
| Investing Cash Flow | -$1.01B | -191.1% |
| Financing Cash Flow | -$19.4M | -368.0% |
| +14.1% |
| EPS (Basic) | $3.14 | +12.5% |
| EPS (Diluted) | $3.00 | +14.1% |